Protein Identification & Global Profiling
Choose this workflow when You need a broad protein inventory or an overall protein profile from serum, plasma, or CSF.
Click to preview →Serum, plasma, and CSF proteomics applies LC-MS/MS-based workflows to characterize proteins in biofluid samples, supporting broad protein profiling, quantitative comparison, and protein-level investigation across well-designed research projects.
MtoZ Biolabs supports protein identification, quantitative proteomics, PTM-related projects, bioinformatics analysis, and integrated omics project planning according to sample type and research goals.
MtoZ Biolabs supports biofluid proteomics projects from sample planning through LC-MS/MS analysis, bioinformatics, and follow-up planning.
This service is suitable when serum, plasma, or CSF samples are used to answer a defined protein-level research question.
The appropriate route should be defined based on the research objective and sample conditions.
Choose this workflow when You need a broad protein inventory or an overall protein profile from serum, plasma, or CSF.
Click to preview →Choose this workflow when You need to compare relative protein abundance across defined groups, conditions, or time points.
Click to preview →Choose this workflow when You need PTM-related peptide or site information and the available sample input is suitable for the selected project.
Click to preview →Choose this workflow when You need to explore protein interactions or protein-complex-related questions using an appropriate enrichment and MS strategy.
Click to preview →Choose this workflow when You want proteomics interpreted together with metabolomics, transcriptomics, or other compatible omics datasets.
Click to preview →Choose this workflow when You have limited serum, plasma, or CSF sample volume and need the analysis plan adjusted to the available input.
Click to preview →After you select a route, this panel will summarize the best next step and carry that choice into the quote form.
A clear path from project review to proteomics analysis and reporting.
Review sample source, group design, and expected output.
Check sample type, amount, condition, and submission information.
Prepare samples according to the selected analysis.
Digest proteins and assess preparation quality.
Acquire proteomics data by LC-MS/MS.
Process data, perform bioinformatics, and deliver the report.
From project review and sample preparation to LC-MS/MS analysis and report delivery.
Submit clearly labeled samples and refer to the MtoZ Biolabs Proteomics Sample Submission Guide for details.
| Sample Type | Recommended Input | Submission Notes |
|---|---|---|
| Serum | 10 µL per sample; 50 µL if high-abundance protein depletion is required | Provide sample ID, species, group information, and available sample details. |
| Plasma | 10 µL per sample; 50 µL if high-abundance protein depletion is required | Provide anticoagulant type, sample ID, species, group information, and available sample details. EDTA or citrate is preferred; heparin is not recommended. |
| CSF | 100 µL per sample recommended; 50 µL minimum may be reviewed | Provide sample ID, species, group information, and available sample details. |
| Limited-Volume / Specialized Samples | Project-dependent | Provide the sample type, sample count, available volume, and project goal for review. |
Deliverables are tailored to the selected workflow and study design.
Project planning, LC-MS/MS analysis, established data processing, and quality-control review.
We review the sample type, analysis route, sample requirements, and expected outputs before project setup.
Interpret proteomics results together with the study design, sample quality, and the selected analytical workflow.
Protein identification, relative abundance comparison, PTM-related findings when selected, functional annotation, and prioritization of proteins or pathways for follow-up research.
Proteomics results alone cannot directly establish causality, functional mechanism, or confirm that an observed protein change is the direct cause of a biological effect.
Sample quality, sample amount, collection and storage consistency, freeze-thaw history, biological variation, group design, preparation method, and LC-MS/MS analytical strategy.
Serum/plasma and CSF differ in recommended input, sample preparation, and handling. Review these differences before planning submission.
| Consideration | Serum / Plasma | CSF |
|---|---|---|
| Recommended input | Routine proteomics: 10 µL recommended, 5 µL minimum. With high-abundance protein depletion: 50 µL recommended, 25 µL minimum. | 100 µL recommended, 50 µL minimum for routine proteomics. |
| Collection & separation | Serum is collected without anticoagulant; plasma is collected with anticoagulant. Samples are separated by centrifugation before freezing. | Collect in a clean tube and clarify the sample before freezing. |
| Pre-analysis handling | Avoid hemolysis and keep collection and processing consistent across comparison groups. | Clarification by centrifugation is recommended; optional filtration may be used according to the project. |
| Aliquot & storage | Aliquot before freezing, store at -80°C, and avoid repeated freeze-thaw cycles. | Aliquot before freezing, store at -80°C, and avoid repeated freeze-thaw cycles. |
| Project planning | High-abundance protein depletion may require additional sample input. | Limited sample volume should be reviewed before finalizing the analysis plan. |
| Shipping | Ship frozen samples on sufficient dry ice and keep handling consistent within the project. | Ship frozen samples on sufficient dry ice and keep handling consistent within the project. |
Frequently asked questions about Serum / Plasma / CSF Proteomics Analysis
Please complete the required fields below. We will review your information and respond with a tailored recommendation.